The ␣-subunit of G proteins of the G 12/13 family stimulate Rho by their direct binding to the RGS-like (RGL) domain of a family of Rho guanine nucleotide exchange factors (RGL-RhoGEFs) that includes PDZ-RhoGEF (PRG), p115RhoGEF, and LARG, thereby regulating cellular functions as diverse as shape and movement, gene expression, and normal and aberrant cell growth. The structural features determining the ability of G␣ 12/13 to bind RGL domains and the mechanism by which this association results in the activation of RGL-RhoGEFs are still poorly understood. Here, we explored the structural requirements for the functional interaction between G␣ 13 and RGL-RhoGEFs based on the structure of RGL domains and their similarity with the area by which RGS4 binds the switch region of G␣ i proteins. Using G␣ i2 , which does not bind RGL domains, as the backbone in which G␣ 13 sequences were swapped or mutated, we observed that the switch region of G␣ 13 is strictly necessary to bind PRG, and specific residues were identified that are critical for this association, likely by contributing to the binding surface. Surprisingly, the switch region of G␣ 13 was not sufficient to bind RGL domains, but instead most of its GTPase domain is required. Furthermore, membrane localization of G␣ 13 and chimeric G␣ i2 proteins was also necessary for Rho activation. These findings revealed the structural features by which G␣ 13 interacts with RGL domains and suggest that molecular interactions occurring at the level of the plasma membrane are required for the functional activation of the RGL-containing family of RhoGEFs.Rho GTPases, which include Rho, Rac, and Cdc42, play a central role in the regulation of a number of basic cellular events such as cell movement and changes in cell shape, as well as in the control of gene expression regulation and cell growth (1). These GTP-binding proteins act as molecular switches that are inactive in their GDP-bound form, and upon exchange of GDP for GTP, they adopt an active conformation in which they can interact with their specific effector molecules, thereby affecting their localization and/or activity (1-3). This nucleotide exchange is promoted by a large family of guanine nucleotide exchange factors (GEFs), 1 the vast majority of which are characterized by the presence of a dbl-homology (DH) and pleckstrin homology (PH) domain (2, 4). These GEFs also exhibit a number of additional regulatory regions by which they are strictly controlled by a diverse array of upstream signaling pathways, including those initiated by cell adhesion molecules, tyrosine kinase growth factor receptors, as well as by G proteincoupled receptors (GPCRs) (2, 5).In particular for Rho, this GTPase participates in many physiological and pathological processes that involve the activation of GPCRs. For example, GPCRs such as those for thrombin and lysophosphatidic acid (LPA) promote cytoskeletal changes and expression from serum responsive element (SRE)-regulated genes by activating Rho (6, 7). Rho also participates in platelet aggre...